The multiple indicator dilution method and its utility in risk assessment

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 5, 2000, Pages 861-872

  Schwab, Andreas J ^a   Pang, K Sandy ^b,c  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Capillary permeability; Liver; Metabolism; Multiple indicator dilution method; Partial differential equations; Physiologically based pharmacokinetic models; Quasi steady state approximation; Risk assessment; Time invariant linear systems; Transport

Indexed keywords

ALBUMIN; BROMSULFOPHTHALEIN; EDETIC ACID; GLUTATHIONE; HIPPURIC ACID; PARACETAMOL; RUBIDIUM; SALICYLAMIDE SULFATE; SODIUM; SUCROSE; TOXIN; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EXCRETION; FLOW KINETICS; HEALTH HAZARD; HEART; INDICATOR DILUTION CURVE; KIDNEY; LINEAR SYSTEM; LIVER; LUNG; MATHEMATICAL ANALYSIS; METHODOLOGY; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; TISSUE DISTRIBUTION;

EID: 0033665191     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.2307/3454320     Document Type: Article

References (115)

1. Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development
2. Physiological pharmacokinetics
3. Physiologic pharmacokinetic models and interanimal species scaling
4. Implications of pharmacokinetic modeling in risk assessment analysis
5. An introduction to the use of physiologically based pharmacokinetic models in risk assessment
6. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice
7. Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE)
8. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol
9. Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model
10. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride
11. Theorems on linear systems
12. Pharmacokinetics in nonlinear and partially compartmentalized systems
13. CODE: A deconvolution program implementing a regularization method of deconvolution constrained to non-negative values. Description and pilot evaluation
14. CXT-MAIN: A software package for determination of the analytical form of the pharmacokinetic system weighting function
15. Model-free deconvolution techniques for estimating vascular transport functions
16. Modeling in the analysis of solute and water exchange in the microvasculature
17. Transcapillary pulmonary exchange of water in the dog
18. A linear method for determining liver sinusoidal and extravascular volumes
19. The permeability of capillaries in various organs as determined by use of the 'indicator diffusion' method
20. Membrane transport and the hepatic circulation
21. Microcirculatory events in the liver and the spleen
22. Transport of inorganic anions in perfused rat liver
23. Carrier-mediated entry of 4-methylumbelliferyl sulfate: Characterization by the multiple-indicator dilution technique in perfused rat liver
24. Octanoate transport in the isolated, perfused rat liver
25. Carrier-mediated uptake and excretion of bromosulfophthalein-glutathione in perfused rat liver: A multiple indicator dilution study
26. Hepatic uptake of bromosulfophthalein-glutathione in perfused Eisai hyperbilirubinemic mutant rat liver: A multiple-indicator dilution study
27. Uptake of a protein-bound polar compound, acetaminophen sulfate, by perfused rat liver
28. 2O, as a reference indicator in liver multiple-indicator dilution studies
29. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: A multiple indicator dilution study
30. Sulfation of acetaminophen by the perfused rat liver: The effect of red blood cell carriage
31. Transport and metabolism of l-lactate in perfused rat liver studied by multiple pulse labelling
32. Transfer of enalaprilat across rat liver cell membranes is barrier limited
33. Salicylamide sulfate cell entry in perfused rat liver: A multiple-indicator dilution study
34. Hepatic uptake of hippurate: A multiple-indicator dilution, perfused rat liver study
35. Untersuchung von Fluβgeschwindigkeiten in der isolierten perfundierten Rattenleber durch Pulsmarkierung mit radioaktiven Substraten und mathematischer Analyse der Auswaschkinetiken
36. Transport of D-lactate in perfused rat liver
37. The capillary and sarcolemmal barriers in the heart. An exploration of labeled water permeability
38. Interactions between capillary exchange, cellular entry, and metabolic sequestration processes in the heart
39. A concurrent flow model for extraction during transcapillary passage
40. Coronary capillary permeability and tissue volumes for sucrose and water in dogs: A comparison of bolus and constant infusion multiple-indicator methods
41. The identification of pulmonary capillary permeability from multiple-indicator data. Effects of increased capillary pressure and alloxan treatment in the dog
42. Relative renal excretion patterns of p-aminohippurate (PAH) and glomerular substances
43. Transcapillary exchange of molecular weight markers in the postglomerular circulation: Application of a barrier-limited model
44. Exchange of multiple indicators across renal-like epithelia: A modeling study of six physiological regimes
45. Tracer oxygen distribution is barrier-limited in the cerebral microcirculation
46. Kinetic analysis of cerebrovascular transport based on indicator diffusion technique
47. Mathematical model for the distribution of isotopic carbon atoms through the tricarboxylic acid cycle
48. Carbon-14 tracer studies in rat-liver perfusion experiments under conditions of gluconeogenesis from lactate and pyruvate
49. Mathematical modeling as strategy for understanding hepatic transport of organic solutes
50. A note on the interpretation of tracer dispersion in the liver
51. On indicator dilution and perfusion heterogeneity: A stochastic model
52. The nature of transcapillary exchange in the liver
53. Vasomotor control of capillary transit time heterogeneity in the canine coronary circulation
54. Effect of the correction of catheter distortion on calculated liver sinusoidal volumes
55. Pulmonary capillary transport function from flow-limited indicators
56. The hepatic extracellular matrix. I: Electron immunohistochemical studies in normal rat liver
57. Aquaporins
58. Initial distribution and rate of uptake of sulfobromophthalein in the liver
59. Hepatic uptake of protein-bound ligands: Effect of an unstirred Disse space
60. Uptake of oleate from albumin solutions by rat liver. Failure to detect catalysis of the dissociation of oleate from albumin by an albumin receptor
61. Hepatic uptake of protein-bound ligands: Extended sinusoidal perfusion model
62. Uptake of monohydric alcohols by liver: Demonstration of a shared enzymic space
63. On the uptake of materials by the intact liver. The transport and net removal of galactose
64. On the uptake of materials by the intact liver. The concentrative transport of rubidium-86
65. Uptake of labeled palmitate by the intact liver: Role of intracellular binding sites
66. Red cell carriage of label: Its limiting effect on the exchange of materials in the liver
67. Distributed-in-space product formation in vivo: Enzymic kinetics
68. Computationally efficient algorithms for convection-permeation- diffusion models for blood-tissue exchange
69. The effects of red cell and tissue exchange on the evaluation of capillary permeability from multiple indicator data
70. Extension of the theory of the multiple-indicator dilution technique to metabolic systems with an arbitrary number of rate constants
71. Distributed metabolic systems in whole organs
72. Uptake of lactate by the liver: Effect of red cell carriage
73. Application of the dispersion model for description of the outflow dilution profiles of noneliminated reference indicators in rat liver perfusion studies
74. A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics
75. An analysis of mathematical models of circulatory indicator-dilution curves
76. A convection-diffusion model of indicator transport through an organ
77. The random walk problem in relation to the physiology of circulatory mixing
78. Notes on the inverse Gaussian distribution and choice of boundary conditions for the dispersion model in the analysis of local pharmacokinetics
79. Interconnected-tubes model of hepatic elimination
80. Comparison of the Dispersion and Goresky models in outflow dilution profiles from multiple indicator rat liver studies
81. Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse Laplace transform (FILT)
82. The modified dipeptide, enalapril, an angiotensin-converting enzyme inhibitor, is transported by the rat liver organic anion transport protein
83. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
84. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals as novel conjugate export pump deficient in hyperbilirubinemic mutant rats
85. Models of hepatic elimination: Comparison of stochastic models to describe residence time distribution and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination
86. Investigation of rapid metabolic reactions in whole organs by multiple pulse labelling
87. Modeling blood flow heterogeneity
88. Applications of the lagged normal density curve as a model for arterial dilution curves
89. Simplifying principles for chemical and enzyme reaction kinetics
90. Clearance concepts in pharmacokinetics
91. Clearance as a quantitative measure of liver function
92. A dispersion model of hepatic elimination. 1: Formulation of the model and bolus considerations
93. A comparative investigation of hepatic clearance models: Predictions of metabolite formation and elimination
94. Distributed-in-space product formation in vivo: Linear kinetics
95. Synthesis, decomposition kinetics, and preliminary toxicological studies of pure N-acetyl-p-benzoquinone imine, a proposed toxic metabolite of acetaminophen
96. From piecewise to full physiologic pharmacokinetic modeling: Applied to thiopental disposition in the rat
97. Determination of the single-pass impulse response of the body tissues with circulatory models
98. Effects of cardiac output on disposition kinetics of sorbitol: Recirculatory modelling
99. Pharmacokinetics in organs and the intact body: Model validation and reduction
100. Accuracy of numerical inversion of Laplace transforms for pharmacokinetic parameter estimation
101. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver
102. The secretory function of the liver: New aspects of hepatobiliary transport
103. Xenon handling in the liver: Red cell capacity effect
104. Three-dimensional observations of the hepatic arterial terminations in rat, hamster and human liver by scanning electron microscopy of microvascular casts
105. Erythrocytes as a total barrier for renal excretion of hydrochlorothiazide: Slow influx and efflux across erythrocyte membranes
106. Erythrocytes as barriers for drug elimination in the isolated rat liver. II: Propranolol
107. Metabolic heterogeneity of liver parenchyma
108. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues
109. Determination and prediction of tissue-gas partition coefficients
110. Development of partition coefficients, Vmax and Km values, and allometric relationships
111. The importance of anatomical realism for validation of physiological models of disposition of inhaled toxicants
112. Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models
113. The hybrid model: A new pharmacokinetic model for computer-controlled infusion pumps